A Leap of Faith? Sanctioning Xenotransplant Clinical Trials.

Fovargue, Sara J. (2005) A Leap of Faith? Sanctioning Xenotransplant Clinical Trials. Liverpool Law Review, 26 (2). pp. 125-147. ISSN 1572-8625

Full text not available from this repository.

Abstract

Introducing a new medical technique, procedure or drug to the public via clinical trials is risky at the best of times. When the trial involves a biotechnology which holds out the promise of prolonging, if not saving, life the push to move from the laboratory to clinical trials may be hard to resist. In this article I explore whether the regulatory scheme for clinical trials in the UK is able to accommodate developing technologies by considering how the current legal and ethical frameworks determine when a procedure such as xenotransplantation should proceed to trials. In particular, I discuss whether basing our regulatory schemes on the principles espoused in the Declaration of Helsinki offer sufficient protection to those who may be affected by xenotransplant trials – the recipient, their health-care workers, close contacts and, unusually, the wider public. I question whether it is possible for a technology to be approved for clinical trials when allowing such trials may benefit the individual but ultimately negatively impact on society as a whole.

Item Type:
Journal Article
Journal or Publication Title:
Liverpool Law Review
Uncontrolled Keywords:
/dk/atira/pure/researchoutput/libraryofcongress/k1
Subjects:
ID Code:
20839
Deposited By:
Deposited On:
03 Dec 2008 13:12
Refereed?:
Yes
Published?:
Published
Last Modified:
11 Mar 2020 02:17